Cardiovascular disease surveillance in the comparative effectiveness landscape.
作者信息
Roger Véronique L
出版信息
Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):404-6. doi: 10.1161/CIRCOUTCOMES.109.901249.
Abstract
摘要
相似文献
1
Cardiovascular disease surveillance in the comparative effectiveness landscape.比较疗效领域中的心血管疾病监测
Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):404-6. doi: 10.1161/CIRCOUTCOMES.109.901249.
2
Cardiovascular science in the service of national strength.心血管科学服务于国家实力。
JAMA. 2011 Nov 16;306(19):2145-6. doi: 10.1001/jama.2011.1669.
3
Towards a new order in cardiovascular medicine: re-engineering through global collaboration.迈向心血管医学的新秩序：通过全球合作进行重新设计。
Eur Heart J. 2010 Apr;31(8):911-7. doi: 10.1093/eurheartj/ehp550. Epub 2010 Feb 3.
4
The Global Burden of Cardiovascular Diseases and Risks: A Compass for Global Action.心血管疾病及其风险的全球负担：全球行动指南。
J Am Coll Cardiol. 2020 Dec 22;76(25):2980-2981. doi: 10.1016/j.jacc.2020.11.021.
5
Increased cardiovascular and renal disease but not reduced life expectancy among diabetic participants in the general Northern Greek population.希腊北方一般人群中糖尿病患者心血管和肾脏疾病增加，但预期寿命并未缩短。
Angiology. 2012 Aug;63(6):443-7. doi: 10.1177/0003319711426423. Epub 2011 Dec 7.
6
[Epidemiology and prevention at the times of the Italian National Prevention Plan 2014-2018].
Epidemiol Prev. 2015;39(3):154-6.
7
[Does a slight overweight increase life expectancy?].[轻微超重会增加预期寿命吗？]
Rev Prat. 2015 Jan;65(1):10-1.
8
[Organization of medical care for patients with cardiovascular diseases].[心血管疾病患者的医疗护理组织]
Med Tr Prom Ekol. 2010(2):36-43.
9
Is a poorly functioning health care system to blame for low life expectancy in the U.S.?美国预期寿命低该归咎于运转不良的医疗保健系统吗？
Natl Bur Econ Res Bull Aging Health. 2009(4):3-4.
10
Costs of cardiac care likely to increase, despite advances in prevention, care.尽管在预防和治疗方面取得了进展，但心脏护理的成本可能会增加。
JAMA. 2013 Nov 20;310(19):2029. doi: 10.1001/jama.2013.282805.
引用本文的文献
1
Epidemiology of cardiovascular disease in Europe.欧洲心血管疾病的流行病学。
Nat Rev Cardiol. 2022 Feb;19(2):133-143. doi: 10.1038/s41569-021-00607-3. Epub 2021 Sep 8.
2
Seasonal and Geographic Patterns in Seeking Cardiovascular Health Information: An Analysis of the Online Search Trends.季节和地理因素对心血管健康信息搜索的影响：在线搜索趋势分析。
Mayo Clin Proc. 2018 Sep;93(9):1185-1190. doi: 10.1016/j.mayocp.2018.07.011.
3
Who Must We Target Now to Minimize Future Cardiovascular Events and Total Mortality?: Lessons From the Surveillance, Prevention and Management of Diabetes Mellitus (SUPREME-DM) Cohort Study.为将未来心血管事件和总死亡率降至最低，我们现在必须针对哪些人群？糖尿病监测、预防与管理（SUPREME-DM）队列研究的经验教训。
Circ Cardiovasc Qual Outcomes. 2015 Sep;8(5):508-16. doi: 10.1161/CIRCOUTCOMES.115.001717.
4
Prognostic value of cardiac troponin T after myocardial infarction: a contemporary community experience.心肌梗死后心肌肌钙蛋白 T 的预后价值：当代社区经验。
Mayo Clin Proc. 2012 Mar;87(3):247-54. doi: 10.1016/j.mayocp.2011.11.013.
本文引用的文献
1
Sustaining improvement in door-to-balloon time over 4 years: the Mayo clinic ST-elevation myocardial infarction protocol.四年间持续缩短首次医疗接触到球囊扩张时间：梅奥诊所ST段抬高型心肌梗死治疗方案
Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):508-13. doi: 10.1161/CIRCOUTCOMES.108.839225.
2
Age- and sex-specific trends in fatal incidence and hospitalized incidence of stroke in Scotland, 1986 to 2005.1986年至2005年苏格兰中风致死率和住院率的年龄及性别特异性趋势。
Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):475-83. doi: 10.1161/CIRCOUTCOMES.108.825968. Epub 2009 Jul 21.
3
Temporal changes in the use of drug-eluting stents for patients with non-ST-Segment-elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the can rapid risk stratification of unstable angina patients supress ADverse outcomes with early implementation of the ACC/AHA guidelines (CRUSADE) and acute coronary treatment and intervention outcomes network-get with the guidelines (ACTION-GWTG) registries.2006年至2008年接受经皮冠状动脉介入治疗的非ST段抬高型心肌梗死患者使用药物洗脱支架的时间变化：来自“能否通过早期实施美国心脏病学会/美国心脏协会（ACC/AHA）指南快速对不稳定型心绞痛患者进行危险分层以抑制不良结局（CRUSADE）”及“急性冠状动脉治疗和干预结局网络-遵循指南（ACTION-GWTG）”注册研究的结果
Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):414-20. doi: 10.1161/CIRCOUTCOMES.109.850248. Epub 2009 Jul 28.
4
Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change.重新思考用于比较效果研究的随机临床试验：变革的必要性。
Ann Intern Med. 2009 Aug 4;151(3):206-9. doi: 10.7326/0003-4819-151-3-200908040-00126. Epub 2009 Jun 30.
5
Comparative effectiveness research: a report from the Institute of Medicine.比较效果研究：医学研究所的一份报告。
Ann Intern Med. 2009 Aug 4;151(3):203-5. doi: 10.7326/0003-4819-151-3-200908040-00125. Epub 2009 Jun 30.
6
The American Heart Association's principles for comparative effectiveness research: a policy statement from the American Heart Association.美国心脏协会关于比较效果研究的原则：美国心脏协会的政策声明
Circulation. 2009 Jun 9;119(22):2955-62. doi: 10.1161/CIRCULATIONAHA.109.192518. Epub 2009 May 11.
7
Comparative effectiveness research: the view from the NHLBI.比较效果研究：美国国立心、肺、血液研究所的观点
J Am Coll Cardiol. 2009 Mar 24;53(12):1084-6. doi: 10.1016/j.jacc.2008.11.047.
8
Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.《2008年心脏病和中风统计数据更新：美国心脏协会统计委员会及中风统计小组委员会报告》
Circulation. 2008 Jan 29;117(4):e25-146. doi: 10.1161/CIRCULATIONAHA.107.187998. Epub 2007 Dec 17.
9
Essential features of a surveillance system to support the prevention and management of heart disease and stroke: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Stroke, and Cardiovascular Nursing and the Interdisciplinary Working Groups on Quality of Care and Outcomes Research and Atherosclerotic Peripheral Vascular Disease.支持心脏病和中风预防与管理的监测系统的基本特征：美国心脏协会流行病学与预防委员会、中风委员会、心血管护理委员会以及护理质量与结果研究和动脉粥样硬化性外周血管疾病跨学科工作组的科学声明
Circulation. 2007 Jan 2;115(1):127-55. doi: 10.1161/CIRCULATIONAHA.106.179904. Epub 2006 Dec 18.
10
Medicine. The NIH Roadmap.医学。美国国立卫生研究院路线图。
Science. 2003 Oct 3;302(5642):63-72. doi: 10.1126/science.1091867.
Zotero 插件